Giving a joint supplement to a dog that shows no clinical signs yet regularly raises the same question: is it a useful step or an unnecessary precaution?

Currently, scientific literature does not provide a definitive answer.

What We Know Today

The vast majority of studies on joint nutraceuticals have been conducted on dogs already suffering from osteoarthritis, with reduced mobility or clinical joint signs.

The available data therefore mainly concerns symptomatic dogs.

There are very few studies evaluating the benefit of supplementation started in a completely healthy dog with the aim of delaying the onset of osteoarthritis.

In practice, this means it is not possible to state that a joint supplement prevents osteoarthritis in a healthy dog.

The absence of proof does not necessarily mean the absence of effect, but it prevents nutritional prevention from being presented as a fact established by science.

In active dogs, the goal is not necessarily to prevent osteoarthritis in the strict sense. It is rather to support joints subjected to repeated stress: sport, work, jumping, acceleration, braking, or changes in support.

In this context, certain ingredients can be part of an early support approach or recovery assistance, without guaranteeing protection against the onset of joint disease.

What Can Be Reasonably Considered

Certain ingredients have mechanisms of action compatible with early use.

Omega-3 EPA and DHA are involved in modulating low-grade inflammation.

Collagen, UC-II®, or certain structural ingredients may also have theoretical interest in situations where joints are particularly stressed.

These arguments are based primarily on biological plausibility and data obtained from dogs already affected or with impaired joint function.

They do not constitute direct evidence of prevention in healthy dogs.

The Main Risk Factors Remain Elsewhere

Canine osteoarthritis is a multifactorial disease.

Genetics, growth, weight, orthopedic history, physical activity level, certain conformations, or certain sports disciplines play a much more important role than supplementation.

An overweight dog retains an increased joint risk, even if it receives a supplement.

Similarly, a dog with dysplasia, ligament rupture, or orthopedic abnormalities will not be "protected" by supplementation alone.

Scientific data also show that weight control remains one of the most important levers for limiting the onset or worsening of joint disorders.

In Which Cases Can the Discussion Make Sense?

Early supplementation can nevertheless be discussed in certain contexts:

• breeds with a high joint risk;
• sporting or working dogs;
• dogs subjected to significant physical stress;
• orthopedic history;
• known dysplasia or developmental abnormalities;
• recovery after certain orthopedic surgeries;
• dogs that have already experienced locomotor episodes.

In these situations, the consideration is more about supporting a at-risk dog than about demonstrated true prevention.

In Healthy Dogs Without Risk Factors

In a dog with no particular history, with an appropriate weight, consistent physical activity, and regular veterinary follow-up, early supplementation does not appear to be a necessity today.

The priorities remain:

• maintaining an appropriate body weight;
• providing regular physical activity;
• avoiding excesses during growth;
• adapting efforts to the dog's lifestyle;
• ensuring appropriate veterinary follow-up.

Supplementation may eventually be discussed later depending on the dog's age, activity, or development, but it is not a systematic recommendation.

________________________________________________________________

Sources

1. Pye C. et al. (2024). Current evidence for non-pharmaceutical, non-surgical treatments of canine osteoarthritis. Journal of Small Animal Practice. Highlights that most trials concern dogs already arthritic, no true demonstrated primary prevention.

2. Frontiers framework / consensus articles on multimodal management of canine osteoarthritis. Importance of weight, exercise, orthopedic context, and global management.

3. Reviews on obesity and canine osteoarthritis: weight remains a major modifiable factor.

4. Molecular articles already sourced from pillar 7: omega-3, UC-II, collagen, ESM, whose data mainly concern symptomatic dogs or those with altered joint function.